Clinical Trial Update: Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating bintrafusp alfa in combination with doxorubicin hydrochloride for advanced or metastatic soft-tissue sarcoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Bintrafusp alfa (bintrafusp alfa)
• DOXORUBICIN HYDROCHLORIDE (Doxorubicin hydrochloride)

Snippet

Sponsor: Institut Bergonié | Conditions: Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma | Phase 2 | Status: RECRUITING